Dapsone

And then this Alzheimer's biomarker showed up and I said to her, listen, I'm finishing one-on-one clinical practice in the next few months.

You've never done Dapsone combination therapy.

I said, I have no idea whatsoever whether this is gonna work and reverse it.

I just know that you do not wanna have this biomarker going forward because it could affect cognition.

Cause she was thinking my meditation practice was explaining why I have good cognition.

I gave her the nine week Dapsone protocol.

We rechecked her Alzheimer's biomarkers three months later.

Lo and behold, we reversed the biomarker, P tau sub 17.

I became a patient of Dr. Richard Horowitz, who does DAP zone therapy.

And, um, that for me really Dapsone therapy changed everything.

Um, so I did, I believe it was a four week course of like, quote unquote, regular Dapsone therapy.

And then I did a two week course of double Dapsone and a four day pulse of quad Dapsone.

And then I also have Babiesia and Bartonella.

And for those of us with co-infections, his rule of thumb and what his research has showed is that you need, I believe it's four double dapsone pulses for the co-infections.

And I mean, it was, it was a process, you know, it was a couple of years of the DAP zone on and off and then letting my body heal and, you know, building it up and coupled with, you know, the, the sub QIG, the immune globulins.

But for me, that's, that's what did it.

Would you like me to check? And she said, okay, but don't tell me.

Just tell me if I have to do Dapsone.

I said, okay.

So she came back and her P tau was high.

You don't have rheumatoid arthritis.

And now I'm showing inflammation in your brain.

I need you to do Dapsone.

She did the nine week protocol.

You mean it persists like tuberculosis and leprosy.

Now, how do they cure leprosy? Rifampin and dapsone for a year.

What did I do? I looked at the qualities of this drug called Dapsone.

So Dapsone number one is anti-inflammatory.

And as we're about to discuss during this podcast, every disease we're going to talk about today, ADD, ADHD, autism spectrum disorder, Alzheimer's disease, allergies and asthma, autoimmune diseases, rheumatoid arthritis, chronic fatigue syndrome, fibromyalgia, cancer, cardiovascular disease, digestive disorders, irritable bowel, inflammatory bowel, hormonal disorders, mood disorders, pain.

Every one of them has all 16 inflammatory factors on the MSIDS model that I discovered in Lyme.

Your immune system doesn't work.

You develop liver disease with fatty liver disease, driving metabolic syndrome and liver inflammation, as well as pain syndromes and mood disorders.

It's the same thing.

So once we started using biofilm agents and persister drugs, like used for tuberculosis and leprosy, that's how I came to Dapsone, we started seeing honestly miraculous results where we did not have to leave people on antibiotics forever.

So it's about three decades for me constantly being in the trenches, just digging.

to figure out what was keeping these people ill and you know now i'm going to be applying for nih grants myself this coming year and hopefully we'll get a randomized controlled double-blind placebo trial on dapsone so i can prove to the world that actually we do have answers

So essentially what's happening is people's immune systems are getting overwhelmed and then you've got mold toxins like gliotoxins that are making the whole thing worse on top of all the heavy metals and other toxins where people's detox pathways aren't working.

Mm-hmm.

So now, whereas I'd say probably six years ago, we were finding Dapsone, of course, was working quite well.

And we kept tweaking it year after year.

it can actually cause a lot of neurodegenerative symptoms.

He, he, he just showed, uh, through a trial using, uh, Dapsone and some other drugs in patients with Alzheimer's and high levels of a thing called p-tau217-

Hmm

... which is a biomarker-

... option, um, to help these patients.

I also, uh, use sometimes Dapsone and petoxiflin.

Right.

But these are not been tested in large scale studies.